Privia Health Group, Inc. · NASDAQ:PRVA
Privia Health — Q1 2026 Earnings Presentation
17 slides from Privia Health's earnings presentation, May 7, 2026
Slide 1: 1st Quarter 2026 Results
1st Quarter 2026 Results Parth Mehrotra, CEO May 7, 2026 David Mountcastle, CFO
Slide 2: Disclaimer
Disclaimer Forward-Looking Statements This presentation contains forward-looking statements that express the Company’s opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results that include, but are not limited to: 2026 financial guidance
Slide 3: Agenda
Agenda ● Key Highlights ● 1Q’26 Performance ● 2026 Guidance and Outlook ● Q&A 3
Slide 4: Continued Momentum with Solid First Quarter Performance
Continued Momentum with Solid First Quarter Performance ● Strong 1Q’26 performance and operational execution ○ Implemented Providers growth +13.6% vs. 1Q’25 ○ Attributed Lives growth +26.5% vs. 1Q’25 ○ Practice Collections growth +14.6% vs. 1Q’25 ○ Adjusted EBITDA1 growth +36.3% (28.5% margin, +290
Slide 5: Building One of the Largest Primary Care Centric Delivery Networks
Building One of the Largest Primary Care Centric Delivery Networks 1 NATIONAL PRESENCE 24 States + Includes 9 VBC-only from D.C. Evolent ACO acquisition 70+ Specialties 1,300+ Care Center Locations 5.9M+ Patients 1.6M+ Attributed Lives* 5,535 Implemented Providers ** 98% Gross Provider Retention***
Slide 6: Diversified Value-Based Platform
Diversified Value-Based Platform 1 1.6+ Million 130+ Total Attributed Lives VBC Contracts 913K 693K Commercial Government • 61% Upside Only Lives Lives • 39% Upside / Downside 336K 221K CMS Medicare 136K Medicare Medicaid Advantage program Lives Lives Lives • 81% Enhanced Track/ • 71% Upside Only • 1
Slide 7: 1Q Performance
1Q Performance 1 Implemented Providers Attributed Lives Practice Collections ($mm) (end of period) (‘000s, end of period)1 +13.6% +26.5% +14.6% Care Margin ($mm) Platform Contribution ($mm) Adjusted EBITDA ($mm) +22.3% +29.6% +36.3% % Practice Collections 6.5% 7.3% % Practice Collections 3.4% 4.0% %
Slide 8: Strong Balance Sheet and Capital Position
Strong Balance Sheet and Capital Position ● $419.5M in net cash and no debt as of 3.31.26 ● 1Q’26 use of cash included annual cash bonuses and physician VBC payments, similar to past years (In millions) At 3.31.26 At 3.31.25 Cash and cash equivalents $419.5 $469.3 Debt -- -- Net cash position $419.5
Slide 9: Updated FY'26 Guidance Metrics
Updated FY’26 Guidance Metrics 1 Initial FY’26 Guidance Updated FY’26 Guidance FY’25 Actual ($ in millions) at 2.26.26 at 5.7.26 Low High Implemented Providers 5,380 5,900 6,000 Unchanged Attributed Lives 1,541,000 1,550,000 1,600,000 1,600,000 - 1,625,000 Practice Collections $ 3,470.5 $ 3,650 $ 3,
Slide 10: Consistent Growth & Profitability Across Cycles
Consistent Growth & Profitability Across Cycles 1 MA / MEDICAID PRE-COVID COVID POST-COVID HEADWINDS 1 Any slight variations in percentages are due to rounding. Management has not reconciled forward-looking non-GAAP measures to their most directly comparable GAAP measures because the Company cannot p
Slide 11: Appendix
Appendix 11
Slide 12: Reconciliation of Gross Profit to Care Margin
Reconciliation of Gross Profit to Care Margin l 12
Slide 13: Reconciliation of Gross Profit to Platform Contribution
Reconciliation of Gross Profit to Platform Contribution m 13
Slide 14: Reconciliation of Net Income to Adjusted EBITDA
Reconciliation of Net Income to Adjusted EBITDA n 14
Slide 15: Reconciliation of Gross Profit to Care Margin
Reconciliation of Gross Profit to Care Margin 15
Slide 16: Reconciliation of Net Income (Loss) to Adjusted EBITDA
Reconciliation of Net Income (Loss) to Adjusted EBITDA 16
Slide 17: Reconciliation of Net Cash Provided by Operating Activities to Free Cash Flow
Reconciliation of Net Cash Provided by Operating Activities to Free Cash Flow 17